These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32313954)

  • 1. Pharmacist-led transitions-of-care program reduces 30-day readmission rates for Medicare patients in a large health system.
    Miller D; Ramsey M; L'Hommedieu TR; Verbosky L
    Am J Health Syst Pharm; 2020 Jun; 77(12):972-978. PubMed ID: 32313954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the effects of a multidisciplinary transition care management program on hospital readmissions.
    Snyder ME; Krekeler CE; Jaynes HA; Davis HB; Lantaff WM; Shan M; Perkins SM; Zillich AJ
    Am J Health Syst Pharm; 2020 Jun; 77(12):931-937. PubMed ID: 32436574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist-led program to improve transitions from acute care to skilled nursing facility care.
    Achilleos M; McEwen J; Hoesly M; DeAngelo M; Jennings T
    Am J Health Syst Pharm; 2020 Jun; 77(12):979-984. PubMed ID: 32377682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a pharmacy team-led intervention program on the readmission rate of elderly patients with heart failure.
    Moye PM; Chu PS; Pounds T; Thurston MM
    Am J Health Syst Pharm; 2018 Feb; 75(4):183-190. PubMed ID: 29436465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis.
    Mekonnen AB; McLachlan AJ; Brien JA
    J Clin Pharm Ther; 2016 Apr; 41(2):128-44. PubMed ID: 26913812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pharmacist's Impact on 30-Day Readmission Rates When Compared to the Current Standard of Care Within a Patient-Centered Medical Home: A Pilot Study.
    Tedesco GW; McConaha JL; Skomo ML; Higginbotham SK
    J Pharm Pract; 2016 Aug; 29(4):368-73. PubMed ID: 25634012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pharmacy interventions at transitions of care on patient outcomes.
    Fosnight S; King P; Ewald J; Feucht J; Lamtman A; Kropp D; Dittmer A; Sampson J; Shah M
    Am J Health Syst Pharm; 2020 Jun; 77(12):943-949. PubMed ID: 32374386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a multidisciplinary approach to reduce internal medicine readmissions using a readmission prediction index.
    McConachie SM; Raub JN; Yost R; Monday L; Agrawal S; Tannous P
    Am J Health Syst Pharm; 2020 Jun; 77(12):950-957. PubMed ID: 32382749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pharmacist intervention in conjunction with outpatient physician follow-up visits after hospital discharge on readmission rate.
    Arnold ME; Buys L; Fullas F
    Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S36-42. PubMed ID: 25991594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a community pharmacy transitions-of-care program on 30-day readmission.
    Shaver A; Morano M; Pogodzinski J; Fredrick S; Essi D; Slazak E
    J Am Pharm Assoc (2003); 2019; 59(2):202-209. PubMed ID: 30552052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the impact of adding pharmacist management services to an existing discharge planning program on 30-day readmissions.
    Peasah SK; Hammond T; Campbell V; Liu Y; Morgan M; Kearney S; Good CB
    J Am Pharm Assoc (2003); 2022; 62(3):734-739. PubMed ID: 34975006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Insurer's Care Transition Program Emphasizes Medication Reconciliation, Reduces Readmissions And Costs.
    Polinski JM; Moore JM; Kyrychenko P; Gagnon M; Matlin OS; Fredell JW; Brennan TA; Shrank WH
    Health Aff (Millwood); 2016 Jul; 35(7):1222-9. PubMed ID: 27385237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis.
    Mekonnen AB; McLachlan AJ; Brien JA
    BMJ Open; 2016 Feb; 6(2):e010003. PubMed ID: 26908524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pharmacist-conducted medication reconciliation at discharge on readmissions of elderly patients with COPD.
    Eisenhower C
    Ann Pharmacother; 2014 Feb; 48(2):203-8. PubMed ID: 24259651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a pharmacist-led multidisciplinary transitions-of-care pilot for patients at high risk of readmission.
    Jones CD; Anthony A; Klein MD; Shakowski C; Smith HK; Go A; Perica K; Patel H; Pell J; Pierce R
    J Am Pharm Assoc (2003); 2018; 58(5):554-560. PubMed ID: 30017370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a pharmacist-driven intervention program on hospital readmissions.
    Shull MT; Braitman LE; Stites SD; DeLuca A; Hauser D
    Am J Health Syst Pharm; 2018 May; 75(9):e221-e230. PubMed ID: 29691265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging gaps in care: Implementation of a pharmacist-led transitions-of-care program.
    Brantley AF; Rossi DM; Barnes-Warren S; Francisco JC; Schatten I; Dave V
    Am J Health Syst Pharm; 2018 Mar; 75(5 Supplement 1):S1-S5. PubMed ID: 29472274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Pharmacist Involvement in Heart Failure Transition of Care.
    Neu R; Leonard MA; Dehoorne ML; Scalia SJ; Kale-Pradhan PB; Giuliano CA
    Ann Pharmacother; 2020 Mar; 54(3):239-246. PubMed ID: 31602994
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving care transitions through medication therapy management: A community partnership to reduce readmissions in multiple health-systems.
    Heaton PC; Frede S; Kordahi A; Lowery L; Moorhead B; Kirby J; Kunze N; Luder H
    J Am Pharm Assoc (2003); 2019; 59(3):319-328. PubMed ID: 30819640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial.
    Renaudin P; Baumstarck K; Daumas A; Esteve MA; Gayet S; Auquier P; Tsimaratos M; Villani P; Honore S
    Trials; 2017 Feb; 18(1):65. PubMed ID: 28183322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.